Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

May 28, 2014 9:00 AM - May 28, 2014 10:30 AM

Online

China Update: Regulatory Changes and Implications

Speakers

Jian  Peng

Jian Peng

Clinical Research Director, Sanofi (China), China

Chen  Yang, JD

Chen Yang, JD

Partner, Sidley Austin LLP Beijing Office, China

Janet  Lu, MS, RPh

Janet Lu, MS, RPh

Head of Regulatory Asia Pacific, Roche , China

Janet Lu, as a licensed pharmacist, joined Roche in Mar 2010 as Head of Regulatory Affairs (RA) Asia Pacific (AP) and also appointed as Deputy Site Head of Product development in AP since Oct 2014. In her role, Janet focuses more on AP New Product Development Strategy and is also accountable for China regulatory deliverables. In the past 23 years, she worked with Pharmacia & Upjohn, Pfizer and MSD and was mainly responsible for RA in China. Before joining industry, Janet was a teacher assistant in Pharmacy Dept. of Shanghai Medical Univ. (FU DAN Univ.). Janet obtained her bachelor degree and master degree from Shanghai Medical Univ. and Peking Univ., majored in Pharmacy and International Pharmaceutical Engineering Management respectively.

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.